Broadwood Partners, L.P.

13F Holdings History for Lineage Cell Therapeutics, Inc. - Common (LCTX)

Symbol: LCTX on NYSE
Investment type: Equity / Common
Latest Disclosed Ownership: 57.8M shares
Security Ownership: 24.5%

NEAL C. BRADSHER ownership in Lineage Cell Therapeutics, Inc. Common (LCTX)

2025-01-28 - NEAL C. BRADSHER has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 57.8M shares of Lineage Cell Therapeutics, Inc. Common (LCTX). This represents 24.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
NEAL C. BRADSHER	24.5%		$27.2M	57.8M			$0.47	13D/A	1/27/2025	28 Jan 2025 20:07:41